A slight upsurge in troponin suggests some damage has occurred, while high levels indicate a person has had a heart attack, the researchers explained. Using this new test, doctors may potentially double the true amount of low-risk patients able to be safely discharged from the emergency room, the researchers reported in the Oct. 8 issue of The Lancet. Use of this approach will probably have main benefits for both individuals and health-care providers, Shah said in a journal news release.Screening for cervical tumor and additional cancers such as breast and prostate, has clear potential for harms in addition to benefits, and these must be weighed before a rational decision about screening could be made carefully, wrote Sheridan and Harris, who are professor and assistant professor of medication, respectively, at UNC's School of Medication. They also hold adjunct appointments at UNC's Gillings School of Global Public Wellness. The analysis noted physicians said these were comfortable with much longer testing intervals, but were worried their patients may not come in for annual check-ups if Pap tests, the screening test for cervical cancer, were not offered.